Dr. Albiges on Immunotherapy in Renal Cell Carcinoma

Dr. Albiges on Immunotherapy in Renal Cell Carcinoma

Dr. Laurescreen-shot-2016-10-18-at-21-03-55nce Albiges, Oncologist, head of the GU Tumor Board at the Gustave Roussy speaking during ESMO 2016 about how immunotherapy has had an impact on the field of renal cell carcinoma (RCC).  Watch the video.

2017-02-23T10:16:12+00:00October 18th, 2016|Immuno-Oncology, Treatment Options|
This website uses cookies and third party services to provide a better service. Please confirm you are okay with this. I agree